Building Infrastructure for Psychedelic Medicine: AI Oversight as the Missing Link

Last month at Psychedelic Science 2025, Danielle Schlosser, our Co-Founder and Chief Innovation Officer had the opportunity to join Lucia Huang, Julie Friedman Simon, and Matias Serebrinsky for a panel on how technology is transforming the psychedelic medicine ecosystem—from early-phase trials to real-world implementation.

As the field edges closer to regulatory approval, we’re entering a critical phase: ensuring that safety, fidelity, and data integrity can scale with the science. This is where mpathic is focused—building the technical infrastructure that allows sponsors and CROs to execute trials with greater standardization, lower risk, and increased confidence.

In psychedelic trials, where psychological support plays a pivotal role, the challenge is unique: sessions are long, nuanced, and difficult to evaluate at scale. Human review alone is too slow and too variable to keep pace with the needs of sponsors or regulators. That’s why mpathic developed an AI platform that provides seamless data capture and immediate session-level oversight.

Our system:

• Reviews 100% of support sessions within minutes of upload, including preparation, dosing, and integration;
  
• Detects deviations from protocol, including those that may go unnoticed by manual review;
  
• Surfaces patterns of risk or inconsistency, helping sponsors intervene early;
  
• Enables standardized, audit-ready documentation that supports both safety monitoring and regulatory compliance.
  

This kind of AI-powered quality monitoring isn’t just a nice-to-have—it’s becoming essential. As psychedelic interventions move from controlled research settings into broader clinical deployment, maintaining the fidelity of the therapeutic model will be critical. Without robust infrastructure, even promising compounds can falter due to inconsistency or preventable errors in delivery.

At mpathic, we’re committed to solving for that. Our platform is designed to help study teams execute with precision—and to ensure that participants receive care that is safe, protocol-aligned, and consistently high-quality.The field is moving fast. But if we want to scale these treatments responsibly, we need systems that are built for accuracy, transparency, and repeatability. I’m proud that mpathic is helping to lay that foundation.